Infliximab for the treatment of rheumatoid arthritis.

Infliximab for the treatment of rheumatoid arthritis.

BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...

Descrición completa

Detalles Bibliográficos
Main Authors: Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P
Formato: Journal article
Idioma:English
Publicado: 2002

Títulos similares

Títulos similares